Key Events This Week
31 Aug: Stock opens at Rs.1,433.05, down 3.33% amid broad market weakness
1 Sep: MarketsMOJO downgrades Senores Pharmaceuticals to Hold
2 Sep: Mixed technical signals emerge despite 1.43% intraday gain
4 Sep: Week closes at Rs.1,427.10, down 0.37% on final trading day

Senores Pharmaceuticals Downgraded to Hold Amid Mixed Technicals and Valuation Concerns
2026-09-02 08:57:08Senores Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has seen its investment rating downgraded from Buy to Hold as of 1 September 2026. This adjustment reflects a nuanced reassessment across four key parameters: quality, valuation, financial trend, and technicals. Despite robust financial performance and market-beating returns, evolving technical signals and valuation metrics have tempered the overall outlook.
Read full news article
Senores Pharmaceuticals Ltd Sees Mixed Technical Signals Amid Price Momentum Shift
2026-09-02 08:10:48Senores Pharmaceuticals Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced a nuanced shift in its technical momentum, reflecting a transition from a bullish to a mildly bullish trend. Despite a recent downgrade in its Mojo Grade from Buy to Hold, the stock’s price action and technical indicators reveal a complex interplay of bullish and bearish signals that investors should carefully analyse.
Read full news article
Senores Pharmaceuticals Ltd is Rated Buy
2026-08-25 10:10:49Senores Pharmaceuticals Ltd is rated 'Buy' by MarketsMOJO, with this rating last updated on 13 August 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 25 August 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news articleSenores Pharmaceuticals Gains 2.54%: 6 Key Factors Driving the Week’s Momentum
2026-08-22 10:00:09
Key Events This Week
17 Aug: New 52-week and all-time high at Rs.1,514
18 Aug: Further 52-week and all-time high at Rs.1,563
19 Aug: New 52-week and all-time high at Rs.1,574
20 Aug: Price correction to Rs.1,515 amid broader market gains
21 Aug: Week closes at Rs.1,514.65, marginally down

Broad-Based Technical Strength Lifts Senores Pharmaceuticals Ltd to 52-Week High of Rs 1574
2026-08-19 11:36:32With a remarkable surge to Rs 1574 on 19 Aug 2026, Senores Pharmaceuticals Ltd has not only reached a fresh 52-week high but also demonstrated a powerful alignment of technical indicators that underpin its current momentum.
Read full news articleClarification sought from Senores Pharmaceuticals Ltd
21-Sep-2026 | Source : BSEThe Exchange has sought clarification from Senores Pharmaceuticals Ltd on September 21 2026 with reference to Movement in Volume.
The reply is awaited.
Clarification On Movement In Volume
21-Sep-2026 | Source : BSEClarification Letter on volume movement in the scrip of the Company
Successful Completion Of USFDA Inspection
11-Sep-2026 | Source : BSEWe are pleased to announce that the USFDA has successfully completed its inspection at the manufacturing facility of Apnar Pharma Private Limited
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available









